2026年11月05日,Nayara宣布完成pre-seed轮融资。本轮由SFC Capital领投。
Nayara 是一家聚焦人工智能领域的科技企业。UK-based healthcare AI company Nayara has closed a pre-seed funding round led by SFC Capital, an early-stage investor in the UK.The funding will support the development and expansion of its AI-powered platform designed to improve communication and support for patients between clinical appointments.Nayara develops AI companions for hospitals, healthcare systems and medical technology companies, providing personalised guidance and helping healthcare professionals stay informed about patients’ needs outside clinical settings.
作为医疗健康领域的融资事件,Nayara的资本动作反映出当前医疗健康赛道仍受资本关注。Nayara aims to address these challenges through AI-powered companions that answer routine questions, provide personalised guidance and emotional support, and proactively check in with patients.According to Gal Moore, co-founder and CEO of Nayara, advances in medical technology have expanded the possibilities of healthcare, while patient support has not evolved at the same pace.We started Nayara with a simple belief: no patient should feel alone in their healthcare journey.
本轮资金的具体用途以公司官方披露为准;后续的产品验证与商业化进展值得持续关注。